Pasar al contenido principal

VALORIZACION DE CONTAMINANTES MEDIANTE SU BIOCONVERSION EN BIOCOMBUSTIBLES Y BIOPRODUCTOS

PID2023-151067OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DA CORUÑA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Pilot-Scale Production of Polyhydroxyalkanoates From Cheese Whey: Assessing the Role of Mixed Microbial Cultures

  • Otero-Logilde, Nuria
  • Morlino, Maria Silvia
  • Campanaro, Stefano
  • Kennes, Christian
  • Veiga, María Carmen
[Abstract] Polyhydroxyalkanoate (PHA) is a biopolymer of great commercial interest due to its similarity to conventional plastic. In this study, polyhydroxyalkanoate production from volatile fatty acids obtained from the fermentation of cheese whey was investigated in three bioreactors at the pilot scale process. The study analysed the effects of organic loading rate (OLR) and solids retention time (SRT) on volatile fatty acids and PHA yields, as well as identified the microbial communities at each stage. In the acidogenic reactor, OLR of 3.5, 4.3, and 6.0 gCOD L⁻¹ d⁻¹ were tested with varying SRT between 5 and 10 days. In the PHA enrichment reactor, three OLR (0.7, 1.1, and 1.5 gCOD L⁻¹ d⁻¹) and SRT of 6, 5, and 4 days were evaluated. In the first bioreactor, cheese whey was converted to volatile fatty acids with an acidification ranging from 69 % to 84 % gCOD gCOD 1 initial effluent . In the second bioreactor, used for enriching biomass capable of accumulating PHA from volatile fatty acids, a yield of 0.27 – 0.33 mmolC 1 PHA 1 PHA g mmolC VFA was achieved. In the final tests of polyhydroxyalkanoate accumulation in a third bioreactor, PHA levels reached 0.50 – 0.79 g DryBiomass . Microbial community analysis performed with genome-focused metagenomic, revealed a predominance of the novel phylum Candidatus Saccharibacteria in the acidogenic reactor and the importance of this phylum in the process of acidogenesis. In the second reactor, the dominant microbial group was from the Rhodocyclaceae family, complemented by smaller populations of genera such as Thauera and species like Plasticicumulans acidivorans., This research was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the European FEDER funds, grant number PID2023-151067OB-I00, and by Xunta de Galicia through the Competitive Reference Research Groups, grant number ED431C 2025/036. Additional funding was provided by the BIALAC project under the CONECTA PEME program (2018), supported by the Galician Innovation Agency (GAIN), Xunta de Galicia. N. Otero-Logilde would also like to thank the financial support provided by the INDITEX Group during her internship. The authors would like to thank the companies EMALCSA S.A., INNOLACT S.L. and ABAKAL S.L. for their contribution.., Xunta de Galicia; ED431C 2025/036
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Sustainable Co-Production of Carotenoids and Lipids by Rhodotorula toruloides Metabolizing Acetate Derived from Carbon Dioxide Fermentation

  • Naveira-Pazos, Cecilia
  • Veiga, María Carmen
  • Kennes, Christian
[Abstract] The ability of Rhodotorula toruloides DSM 4444 to metabolize low-cost carbon sources such as fatty acids was comprehensively studied. This organism is shown, for the first time, to simultaneously accumulate microbial oils (biofuel precursors) and carotenoids from acetic acid obtained from CO2 fermentation. This fatty acid is typically the single end product of acetogenic bioconversion of one-carbon gas pollutants (e.g., CO2 and CO). In the first set of experiments, different aerobic fermentations were carried out in automated bioreactors, with acetic acid in one case and with glucose, a more conventional carbon source, as a control, in another bioreactor. R. toruloides consumed around 80 g/L substrate under both conditions. Maximum lipid content (27.2% g/g dry weight) was reached from 38 g/L glucose, while carotenoid content was higher with acetic acid (1.4 mg/g cell after 54.1 g/L acetic acid consumed), representing a 40% increase compared to glucose (1.0 mg/g cell after 64.2 g/L glucose consumed). Additionally, in the second set of assays, a fermented broth produced by Acetobacterium woodii from CO2 fermentation, containing residual nutrients and metabolites, was tested. Despite its complex composition, R. toruloides grew and produced carotenoids (up to 0.141 mg/g), showing potential adaptability. To the best of our knowledge, this is the first report on a greenhouse gas-based biotechnological process as a promising sustainable alternative for the valorization of pollutants, e.g., gas emissions, their bioconversion to VFAs, such as acetic acid, and subsequent fermentation of the carboxylic acid into microbial oils, as a source of renewable energy, as well as carotenoids as a high-value nutraceutical product., This research is part of a project funded by the Spanish Ministry of Science and Innovation and European FEDER funds (PID2023-151067OB-I00). The authors, belonging to the BIOENGIN group, thank Xunta de Galicia for the financial support to Competitive Reference Research Groups (ED431C 2025/36)., Xunta de Galicia; ED431C 2025/36
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Encapsulation of Transforming Growth Factor-β3 in Poly(hydroxybutyrate-co-hydroxyvalerate) Nanoparticles for Enhanced Cartilage Tissue Engineering

  • Rodríguez-Cendal, Ana Isabel
  • Señarís-Rodríguez, José
  • Piñeiro-Ramil, María
  • Cabarcos Mouzo, Loreto
  • Veiga-Barbazán, María del Carmen
  • Meijide-Faílde, Rosa
  • De-Toro, Javier
  • Fuentes Boquete, Isaac Manuel
  • Díaz-Prado, Silvia
[Abstract] Poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) is a naturally occurring biopolymer belonging to the polyhydroxyalkanoate (PHA) family. Due to its excellent properties (biocompatible, biodegradable, and non-toxic), this biopolymer is presented as a very suitable option for use in regenerative therapy as a drug delivery system (DDS). The protein encapsulated in this study is transforming growth factor β3 (TGF-β3), which plays a key role in the chondrogenic differentiation of mesenchymal stem cells (MSCs). The main objective of this work is to evaluate the efficacy of PHBV nanoparticles (NPs) produced from a dairy by-product (whey) as a DDS of TGF-β3 for cartilage regeneration and extracellular matrix (ECM) synthesis and to reduce the complications associated with multiple high doses of TGF-β3 in its free form. For this purpose, biopolymer cytotoxicity, factor release, cell viability, cell proliferation, and differentiation were analyzed. The results showed that the biomaterial purified with chloroform and ethanol, either by single or double precipitation, was not toxic to cells. A sustained release profile was observed, reaching its maximum around day 4. The TGF-β3 NPs promoted the differentiation of MSCs into chondrocytes and the formation of ECM. In conclusion, PHBV demonstrated its potential as an optimal material for DDSs in cartilage regenerative therapy, effectively addressing the key challenge of the need for a single delivery method to reduce complications associated with multiple high doses of TGF-β3., Instituto de Salud Carlos III—General Subdirection of Assessment and Promotion of Research—European Regional Development Fund (FEDER) “A way of making Europe” (PI20/00933) and the Spanish Ministry of Economy and Competitiveness (MINECO) through European FEDER funds (PID2023-151067OB-I00), ayudas para proyectos Semilla-Disruptivos entre grupos del CICA 2021 (POLIBIOMED) of Universidade da Coruña, Grupos con Potencial de Crecemento (ED431B 2020/55 and ED431B 2023/58), Grupos de Referencia Competitiva (ED431C 2021/55) of Xunta de Galicia, and proyectos de Desarrollo y Transferencia 2022 and 2024 of Fundación Pública Gallega de Investigación Biomédica (INIBIC). A.I.R.-C. is currently employed by the Grupos con Potencial de Crecemento, Xunta de Galicia project (ED431B 2023/58).